Manganese

Quick links to important sections

Manganese

Selected form

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Manganese

Property Description
Active Ingredient Manganese Chloride (MnCl₂)
Form Sterile Solution for Injection
Pharmacological Class Trace Element Supplement / Electrolyte
General Purpose Correcting Manganese deficiency
Origin Inorganic Salt (mineral)

What is Manganese Chloride and What Class of Medicine is It?

Manganese Chloride is a pharmaceutical preparation of the essential trace element Manganese (Mn), formally classified as a Trace Element Supplement and an Electrolyte Replacement. This medicine is an inorganic salt used to provide the body with this naturally occurring mineral, which is vital for maintaining metabolic function. Manganese is one of seven trace elements considered essential for human nutrition.


The body requires Manganese in small, specific quantities because it cannot produce the mineral itself. This necessity places it within the category of supportive micronutrients, distinguishing it from synthetic pharmacological agents. Manganese is clinically recognized for its non-substitutable role in vital physiological processes.

Form and Composition: What Makes Up Manganese Chloride Injection?

Manganese Chloride is typically formulated as a Sterile Solution for Injection, designed specifically for intravenous (parenteral) delivery. The medication's core composition is the active ingredient Manganese Chloride dissolved in an Aqueous Vehicle (Water for Injection). This preparation is a crucial component in comprehensive nutritional support.


This sterile, liquid preparation ensures the Manganese bypasses the digestive system, guaranteeing its full bioavailability for patients who require highly controlled nutritional input, such as those receiving Total Parenteral Nutrition (TPN). This targeted administration method is a key differentiating factor from general oral supplements.

What is the General Purpose of Manganese Supplementation?

The general purpose of administering Manganese Chloride is to prevent or correct a deficiency of the essential trace element Manganese. Supplying this micronutrient supports the body's internal systems by fulfilling its role as a necessary cofactor for numerous vital enzymes.


Manganese is critical for enzyme activation and the proper metabolism of carbohydrates, amino acids, and cholesterol. This element is essential for making sure the body can correctly process nutrients and protect cells. Its utility is rooted in maintaining the structural integrity and metabolic regulation necessary for healthy tissues.

Regulatory References

  1. NIH Fact Sheet for Health Professionals: Manganese

What side effects are possible with Manganese?

Possible Side Effects and Safety Information: Manganese

The official safety profile for Manganese is primarily structured around the risk of toxicity resulting from chronic overexposure or accumulation, as opposed to standard adverse reactions from typical intake. Manganese is an essential trace element, but high levels can be neurotoxic.

Serious Adverse Reactions

The most serious documented risk from chronic, excessive Manganese exposure is the development of Manganism, a severe and irreversible neurological syndrome. Symptoms often resemble those of Parkinson's disease, including motor difficulties like rigidity, bradykinesia (slowness of movement), and an unsteady gait, potentially leading to permanent neurological damage.

System-Organ-Class Focus

The regulatory safety profile focuses on the Nervous System Disorders and Psychiatric Disorders as the primary systems affected by toxicity.

Safety Restrictions and Vulnerable Populations

Official regulatory documents note specific safety considerations and limitations:

  • Hepatic Impairment: Individuals with pre-existing liver disease or biliary obstruction are at an increased risk of accumulation and subsequent neurotoxicity because Manganese is mainly excreted through bile. Administration (especially intravenous) may be restricted or require dose reduction in these patients.
  • Exposure-Related Risk: Serious toxicity results from prolonged, chronic exposure (e.g., occupational inhalation or long-term high-dose intravenous nutrition) and not typically from standard dietary supplementation.
  • Monitoring: Regulatory guidance requires the periodic monitoring of blood Manganese levels in patients receiving long-term total parenteral nutrition (TPN) to prevent neurotoxicity, particularly in vulnerable populations like infants.

This framework ensures that risks are managed by controlling total exposure and monitoring at-risk patients.

Overdose and Emergency Response

Manganese Overdose and When to Seek Help

The official regulatory documents define two patterns of Manganese toxicity that necessitate urgent medical attention.


Documented Overdose Presentations and Scope

Acute, high-dose exposure, typically from massive or rapid administration, is officially documented to cause clinical signs such as skin flushing and acute pancreatitis. More critical is the risk of chronic accumulation, which is associated with irreversible neurological toxicity affecting the Central Nervous System. Clinical manifestations of chronic toxicity include neuropsychiatric symptoms, seizures, and parkinsonian-like tremors, such as dysarthria and halting gait. The accumulation is correlated with elevated whole blood manganese concentrations and visible MRI evidence of brain deposition.


Emergency Actions and Monitoring Requirements

If Manganese toxicity is suspected, regulatory guidance mandates that the supplement must be temporarily discontinued. Urgent medical evaluation is required upon the detection of any neurologic signs or symptoms. Management involves supportive measures and specific monitoring: routinely measuring whole blood manganese concentrations and liver tests. Additionally, a brain MRI evaluation is required to be considered if toxicity is suspected. The official prescribing information does not explicitly document a specific antidote.


Population-Specific Risk

A significant regulatory note highlights that patients with hepatic impairment, including those with cholestasis or cirrhosis, are at an increased risk of manganese brain deposition and neurotoxicity due to compromised element excretion.

Therapeutic Uses of Manganese

What Manganese Treats: Main Uses and Benefits

The administration of Manganese Chloride injection is applied as a therapy to manage a lack of this essential mineral, primarily used to manage or prevent a deficiency, particularly in patients requiring nutritional support. The injection in this context helps to maintain manganese serum levels and may be part of symptomatic management to prevent depletion of endogenous stores and subsequent deficiency symptoms.


This therapy is relevant in clinical settings that involve acute or unstable symptom patterns, such as during Total Parenteral Nutrition (TPN), and assists with maintaining functional stability where the underlying issue is a mineral shortage. The main therapeutic benefit contributes to improving metabolic regulation and helps with managing symptoms related to metabolic processing of carbohydrates, fats, and amino acids. Manganese replacement is applied in addressing symptoms related to skeletal and connective tissue integrity, as well as systemic functional deficits like altered glucose tolerance and certain skin rashes.

“This treatment provides support that helps ease the overall symptom burden associated with systemic imbalance.”

Quick Fact: Relief for Functional Strain Manganese replacement supports general well-being during symptomatic phases by helping to manage symptoms that create noticeable physiological strain associated with the lack of this essential mineral.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Who can and cannot use Manganese?

Eligibility for Manganese Chloride Injection, an essential trace element supplement, is defined by regulatory bodies based on the established use, organ function, and administration method.


Official Eligibility Statuses

Category Regulatory Status Restriction Details
Adult Use Allowed Approved as an additive to intravenous solutions for Total Parenteral Nutrition (TPN).
Pediatric Use Safety Not Established Safety and effectiveness have not been established for the single-entity injection.
Administration Route Contraindicated Must not be used for direct intramuscular or intravenous injection due to the solution's high acidity.

Condition-Based Restrictions

Use is highly restricted in certain populations due to the risk of accumulation:

  • Hepatic Impairment: Patients with cholestasis or cirrhosis are at increased risk of manganese brain deposition and neurotoxicity because the primary elimination route is the biliary system. Monitoring is required, and supplementation may be discontinued.
  • Renal Impairment: Patients with impaired kidney function, including premature neonates, require caution due to the risk of aluminum accumulation (an impurity in the product).

Pregnancy and Lactation

Regulatory documents state that the medicine should be given to a pregnant woman only if clearly indicated. Caution must be exercised when administered to a nursing mother, as it is not known if the drug is excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Manganese Chloride Injection describes interaction patterns primarily based on the product’s use in complex intravenous solutions and its mandatory route of elimination.


Documented Interaction Patterns

Interaction Type Interacting Substance / Condition Official Restriction or Outcome
Drug-Drug (Chelation) Trientine Officially identified as a substance known to interact.
Incompatibility (Admixture) Alkaline solutions; Inorganic Phosphate The solution must not be added due to risk of precipitation/instability.
Exposure Modification Hepatic or Biliary Dysfunction Causes decreased elimination and subsequent increased risk of accumulation.
Contaminant Risk Aluminum (product contaminant) Risk of toxicity is heightened in patients with Renal Impairment due to reduced clearance.

Administration Timing and Restrictions

Official labeling contains specific mandatory rules for administration and co-administration:

  • Timing Separation: Multivitamin additives, including Manganese, must be added to the final parenteral nutrition solution shortly before infusion to prevent incompatibility issues.
  • Contraindicated Route: Direct intravenous or intramuscular injection of the concentrated solution is contraindicated due to the acidic pH of the product, which may cause severe local irritation. This product must only be used as a diluted component in an admixture.

Mechanism of Action

The mechanism of Manganese is defined by its role as an essential constituent element, enabling the function of critical metalloenzymes. It operates as an obligate cofactor rather than by initiating a traditional pharmacological effect.

Enzyme Cofactor and Metabolic Regulation

Manganese acts as an obligate cofactor for enzymes like Pyruvate Carboxylase and Arginase, directly enabling their catalytic function in intermediary metabolism. This mechanism enables stable energy production (ATP synthesis) and facilitates the primary pathway for the metabolism of ammonia (the Urea Cycle), which contributes to systemic metabolic regulation.

Cellular Protection via Antioxidant Defense

A central mechanistic role is the incorporation of the Mn^2+ ion into Mitochondrial Superoxide Dismutase (MnSOD). MnSOD is a key component of the cell's defense against reactive oxygen species (ROS) generated during energy metabolism. Activation of this enzyme system facilitates cellular defense against oxidative damage, maintaining the functional status of high-demand tissues, including the central nervous system.

Structural Support for Connective Tissue

Manganese is required as a cofactor for specific glycosyltransferases. This function facilitates the biosynthesis and structural composition of proteoglycans, which are components of the organic matrix found in cartilage and bone.

Dosage and Administration Information

How Manganese is Used: Official Administration Guidelines

Administration of Manganese Chloride is governed by strict procedural rules outlined in regulatory documents, which define its use as a component of parenteral nutrition. The medicine is classified for intravenous (IV) use only and must never be administered orally or as an undiluted bolus injection.

Dosing and Frequency Patterns

The dosage is primarily for maintenance, designed to prevent deficiency of the essential trace element. For most stable adult patients, the official maintenance dosage typically ranges from 0.5 to 2.5 mg of elemental manganese per day. The full daily dose is generally administered once daily as part of a continuous intravenous infusion.

Feature Official Usage Principle
Route of Administration Strictly Intravenous (IV).
Preparation Requirement The concentrated solution must be diluted into a large volume parenteral fluid (e.g., Total Parenteral Nutrition).
Standard Adult Dose 0.5 to 2.5 mg per day for maintenance.
Pediatric Use Requires a substantially lower dose (e.g., 2 to 10 mcg/ kg/ day).
Special Constraint Dosing may be reduced or omitted in patients with severely impaired bile secretion (hepatic dysfunction) due to the element's primary route of excretion.

Procedural Structure

The medicine is used by first ensuring the correct daily dose is calculated, then aseptically adding this dose into the final Total Parenteral Nutrition (TPN) admixture. This mixture is then delivered slowly via continuous intravenous infusion over a period such as 8 to 24 hours. This protocol ensures the manganese is delivered consistently for long-term metabolic support.

Recent Clinical Evidence

Manganese: Recent Clinical Evidence

Manganese (Mn) is an essential trace element required for human health, serving as a cofactor for several key enzymes involved in metabolism, bone formation, and the body's antioxidant defense system. Clinical research typically focuses on its complex role in health, particularly the balance between required intake and potential toxicity.


Role in Metabolic and Structural Health

Recent evidence supports the role of manganese in bone health by modulating the activity of bone-forming cells (osteoblasts) and bone-resorbing cells (osteoclasts), which is central to bone remodeling. It is also a critical component of Manganese Superoxide Dismutase (MnSOD), an antioxidant enzyme primarily located in the mitochondria that assists in protecting cells from oxidative stress. Deficiency is considered rare in the general population, as manganese is widely available in many foods.


Focus on Neurological Balance

Research has increasingly investigated the neurological effects of manganese, focusing on both deficiency and overexposure. The essentiality of manganese requires tight homeostatic control, as excessive accumulation, often linked to occupational exposure or contaminated water, can lead to a neurodegenerative condition called manganism. This condition presents motor and cognitive symptoms that share some characteristics with Parkinson's disease. Studies suggest that the neurotoxicity is associated with the accumulation of the metal in the basal ganglia region of the brain. An inverted U-shaped relationship has been observed between manganese levels and certain neurological and musculoskeletal outcomes, suggesting that both very low and very high levels may be associated with adverse effects. The element’s metabolism and transport are subjects of ongoing investigation, especially regarding genetic factors that influence its regulation.

Frequently Asked Questions (FAQ)

Common questions about Manganese (FAQ)

Q: What is manganese and what is its role in the body?

A: Manganese is an essential trace mineral found naturally in many foods and is available as a dietary supplement. It plays a key role in numerous bodily functions. It is required for the proper function of certain enzymes, which are proteins that speed up chemical reactions. These enzymes are involved in metabolism (how the body uses food for energy), bone formation, and supporting the immune system. Manganese is also involved in the protection of cells from damage.


Q: What foods are good sources of manganese?

A: Manganese is widely distributed in the diet. Rich sources include whole grains (like brown rice and oatmeal), nuts (such as pecans, almonds, and hazelnuts), legumes (like chickpeas and lentils), leafy green vegetables (like spinach and kale), and certain spices (like cloves and turmeric). Tea is also considered a significant source.


Q: What is the recommended daily intake (RDI) of manganese?

A: The recommended daily intake (RDI) for manganese varies by age and life stage. For adult men, the Recommended Dietary Allowance (RDA) is generally 2.3 milligrams (mg) per day, and for adult women it is typically 1.8 mg per day. Higher intake may be recommended for pregnant or breastfeeding women. It is important to consult a healthcare professional for personalized recommendations, as needs can differ.


Q: Can I get too much manganese (manganese toxicity)?

A: Yes, it is possible to consume too much manganese, which can lead to toxicity. The body usually maintains manganese balance by limiting absorption and increasing excretion. However, high intake, especially from occupational exposure (such as inhaling manganese dust or fumes) or long-term high-dose supplementation, can cause negative effects. Symptoms of high manganese exposure can include neurological problems, such as tremors, difficulty walking, and other movement disorders, which may resemble Parkinson's disease. The established Tolerable Upper Intake Level (UL) for adults is 11 mg per day from food and supplements.


Q: Is there a medical condition linked to manganese deficiency?

A: Manganese deficiency is rare in humans. The mineral is abundant in many foods, and the body requires only small amounts. In controlled experimental settings, low manganese intake has been associated with symptoms such as impaired growth, changes in carbohydrate and fat metabolism, and skin irritation. However, these are not typically seen in healthy individuals consuming a varied diet.

How should Manganese be stored and disposed of?

How to Store and Dispose of Manganese

Official regulatory documents detail specific requirements for the storage, handling, and disposal of manganese solutions. The prepared admixture solution must be stored under refrigeration between 2 C to 8 C (36 F to 46 F) and protected from light to maintain stability. When refrigerated and light-protected, the solution is stable for up to nine days. Once removed from refrigeration, the infusion must be completed within 24 hours.

Before administration, the solution must be visually inspected for any signs of particulate matter or discoloration; if instability is observed, the solution must be immediately discarded. The drug product is supplied as a single-dose vial, requiring that any unused portion remaining in the vial or the prepared admixture must be disposed of according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Manganese found in:

A-Z Index: